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Abstract
HIV-1 vertical transmission is thought to mainly take place by virus crossing the placental barrier. However, the mechanism by which
HIV-1-infects placental cells remains to be elucidated. We have found that purified cytotrophoblasts as well as trophoblastic cell lines are
susceptible to infection by different HIV-1 isolates as detected by DNA-PCR and release of infectious virus, although with very low
efficiency. Purified trophoblast or trophoblastic cell lines express low levels of chemokine receptors CCR-5 and CXCR-4 but not CD4 on
the cell surface. To test if those molecules were used as receptors for HIV-1 infection, placental cells were pretreated with antibodies to CD4,
CC-chemokines, C-X-C chemokines. None of those treatments inhibited HIV-1 infection. In contrast, we have found that HIV-1 infection
of placental cells was increased in cocultures of infected T-cell blasts and placental cells. More interestingly, antibodies to 2 integrins and
to LFA-1 were able to significantly block infection of placental cells. Cell surface expression of ICAM-1, an adhesion molecule involved
in attachment of leukocytes to placenta, was upregulated in HIV-1-infected placental cells. Placental cells were able to transfer HIV-1
infection to T-cell blasts. This transmission required cell to cell contact and was also inhibited by anti-LFA-1 antibodies. In summary our
results suggest that placental trophoblast could be infected by HIV-1 by a mechanism involving T cell to placental contact. Moreover,
placental infection enhanced ICAM-1 expression and leukocyte adherence, an event which was required to transfer HIV-1 infection to T
cells. This provides an explanation of the virus passing through the placental barrier during in utero HIV-1 vertical transmission.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Vertical transmission of HIV-1 is mainly produced at
three different periods: antenatally, peripartum or postna-
tally (Pizzo and Butler, 1991). Most efforts have been con-
ducted to prevent the antenatally virus transmission. How-
ever, it has been estimated that around 30% of the vertically
HIV-1 infected children acquire the infection in early preg-
nancy, in utero (Alonso et al., 1998). Clinically, children
infected in utero show a distinctive pattern of AIDS pro-
gression and/or opportunistic infections characteristic of
AIDS (Mofenson and Wolinsky, 1993). In this case, the
virus could pass through placental barrier from maternal to
fetal blood. In fact, the presence of virus in tissues obtained
from fetus in different gestational ages and in different
placental tissues has been demonstrated (Mattern et al.,
1992; Papiernik et al., 1992; Soeiro et al., 1992). Thus, the
infection of placental cells could be directly involved in the
entry of the virus to the fetal blood.
On the other hand, placental inflamation, as chorioam-
nionitis, has been found more often in HIV-1 infected preg-
nant women than in healthy women. This inflamation could
produce placental damage, which in turn may favor the
virus entering placental into tissues (Schwartz and Nahmias,
1991; Wabwire-Mangen et al., 1999). In addition, inflam-
matory cytokines are known to increase HIV-1 replication
(Alonso et al., 2000; Munoz-Fernandez et al., 1997; Poli et
al., 1994). Inflammatory cytokines may also lead to adverse
effects on the placental barrier by damaging the placental
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trophoblast (Raghupathy, 1997). In all these instances, the
exposure of susceptible placental cells to the virus and
subsequent infection could be increased. On the other hand,
there is little direct evidence about placental cell infection.
Viral antigens and nucleic acids have been identified in
placental tissue from HIV-1 infected women by immuno-
cytochemistry and in situ hybridization (Chandwani et al.,
1991; Lewis et al., 1990; Mattern et al., 1992; Maury et al.,
1989; Moussa et al., 1999; Sheikh et al., 2000). However,
the type and distribution of the infected placental cells is not
clear. The trophoblast cellular layer is in direct contact with
maternal blood and it would be a good candidate to become
infected by HIV-1 and to transmit the infection to the fetus.
This hypothesis has caused some controversy and contra-
dictory results have been reported about both susceptibility
to placental cells HIV-1 infection (David et al., 1992; Doug-
las et al., 1991; Mano and Chermann, 1991; Zachar et al.,
1991a) as well as their ability to express the viral receptor
CD4 in their cell surface (Lairmore et al., 1993; Maury et
al., 1989; Zachar et al., 1991b).
Here, we have studied the susceptibility of trophoblast
cells to in vitro HIV-1 infection and the viral ability of
HIV-1 to replicate in this cellular type. Furthermore, we
have studied the mechanism of viral infection including
expression of viral receptors and coreceptors of trophoblast
cells.
Our results indicate that placental trophoblast cells de-
rived from normal placental tissue or transformed tropho-
blastic cell lines could be infected by several different
HIV-1 isolates although virus did not seem to use the CD4
receptor molecule or chemokine receptors for entry. More
interestingly, HIV-1 infection was greatly enhanced by
coculturing placental cells with HIV-1 infected PBMC in a
LFA-1 (CD11a) dependent manner. Besides, HIV-1 infec-
tion induced an increase in ICAM-1 (CD54) expression in
placental cells and adhesion of PBMC to the infected cells.
This adhesion to transfer much more efficiences the virus to
T cells. Moreover, antibodies against LFA-1 or 2-integrins
significantly inhibited both T-cell adhesion to infected pla-
cental cells and HIV-1 infection. Taken together, our results
may provide an explanation to the mechanism by which
HIV can cross the placental barrier and infect the fetus in
utero.
Results
Susceptibility of placental cells to HIV-1 infection
In order to determine the ability of HIV-1 to infect
placental tissue, we selected four HIV-1 strains with differ-
ent cellular tropism. Thus, laboratory isolates HIV-1NL4.3
(lymphotropic X4), HIV-1BaL (macrophage-tropic R5), as
well as primary isolates HIV-11498I (SI and lymphotropic
X4), and HIV-12069I (macrophage-tropic R5) obtained from
infected pregnant women in our laboratory were employed.
Purified cytotrophoblast as well as placental cell lines JAR
and JEG-3 were used, since those two cell lines show many
characteristics of placental trophoblast (Kohler and Bridson,
1971; Pattillo and Gey, 1968). Cells were cultured with
these different viral strains for 4 h and then intensely
washed to remove non-internalized virus. In those condi-
tions proviral DNA could be detected up to 6 days after
infection in any of the cellular types infected with any of the
four viral strains (Fig. 1A), indicating HIV-1 entry and
integration. To discriminate between latent infection and
low viral replication, we quantified viral load in the culture
supernatant, which is a more sensitive technique than p24
antigen. Viral load could be detected in the supernatant of
infection JAR cell line, 4 days after infection with any of the
four viral isolates. A representative experiment is shown in
Fig. 1B. Similar results were obtained with purified cytotro-
phoblast and the JEG-3 cell line (not shown). Those results
indicate that all strains, regardless of their tropism and
phenotype, replicated at detectable although variable levels
in placental cells. To confirm active replication we exam-
ined the kinetics of infection in the JAR cell line, quanti-
fying the viral load levels in the culture supernatant at
different time-points after infection with the primary iso-
lates HIV-11498I (X4). The results showed a significant
increasing of viral load from 0 to 12 h peaking at 24 h after
the infection. This was followed by a decrease, suggestive
of a persistent infection, with low levels of viral replication
(Fig. 1C). This was also suggested by the fact that no
cytopatic effect was observed, as the viability of HIV-1
infected placental cells was always greater than 95% over
the entire 6 day culture period. Moreover, PCR with primers
of human Alu and HIV-1 sequences gave positive results
(data not shown).
Mechanism of entry of HIV-1 into placental cells
CD4 is the main HIV-1 receptor in lymphocytes, al-
though the chemokine receptors CXCR4, CCR5, and
CCR3, among others, have been found to act as HIV-1
coreceptors (Chandwani et al., 1991; Hesselgesser et al.,
1997). Since placental cells could be infected by HIV-1, we
investigated whether the virus could use these receptors
and/or coreceptors to enter the cells. We could not detect
any CD4 positive cells by flow cytometry in purified tro-
phoblasts and the JAR cell line (not shown). To confirm this
we performed RT-PCR for CD4 mRNA, which is a more
sensitive technique, in JAR cell line and in primary tropho-
blast cultures, before or after HLA negative selection. CD4
mRNA could be amplified in placental cells before purifi-
cation by negative selection but not in purified trophoblasts
(Fig. 2A). To further discard the implication of CD4 in
HIV-1 entry in the trophoblastic cells, neutralization exper-
iments with anti-CD4 antibodies on HIV-1 infection were
carried out. The cell line JAR was incubated with two
anti-CD4 (OKT4A and Leu3a) monoclonal antibodies and
after washing the cells HIV-1NL4.3 (X4) and HIV-1BaL (R5)
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virus were added. PBMC were used as a positive control.
No blocking effect of anti-CD4 monoclonal antibodies
could be detected in the JEG-3 cell cultures, while the
inhibition reached 99% in PBMC (Fig. 2B). Similar results
were obtained with purified cytotrophoblast and the JEG-3
cell line (data not shown).
On the other hand, low levels of CXCR4 expression was
detected by flow cytometry of JAR cells and JEG-3 cells
(Fig. 3A). No CCR5 was detected by flow cytometry in
those cell lines (data not shown). CXCR4, CCR3 and CCR5
mRNA expression was also analysed by RT-PCR. Primary
purified trophoblast cells expressed CCR5 and CXCR4
mRNA whereas JAR and JEG-3 cell lines expressed
CXCR4, CCR5, and CCR3 mRNA (Fig. 3B). Since mRNA
Fig. 1. Infection of placental cells by different HIV-1 isolates. Purified
cytotrophoblast cells and JAR and JEG-3 cell lines were infected with
0.1 m.o.i. of the primary isolates HIV-12069I (R5) and HIV-114981 (X4), as
well as with the established strains HIV-1NL4.3 (X4) and HIV-1BaL (R5) or
mock infected with heat inactivated HIV-1NL4.3 (10 m.o.i.). (A) HIV-1
viral DNA was detected in the cell cultures by nested PCR of the pol region
of HIV-1 6 days after infection. Lane 1, mock-infected cells; lanes 2–5,
placental cells infected with HIV-1NL4.3, HIV-1BaL, HIV-12069I and HIV-
11498I, respectively; lane 6, negative control; and lane 7, positive control of
an infected T-cell line. (B) Viral load was quantified in the supernatants of
cultures of JAR cells by RT-PCR 4 days after infection, with the four
isolate. (C) Kinetics of virus release to supernatants. Viral load was
quantified by RT-PCR in the supernatant of JAR cell lines at the indicated
times hours after infection with HIV-11498I.
Fig. 2. Role of CD4 in HIV-1 infection of placental cells. (A) CD4 mRNA
expression, CD4 mRNA was extracted from placental cells and detected by
RT-PCR. Lane 1, primary trophoblasts before HLA negative selection;
lane 2, primary purified trophoblasts after HLA negative selection; lane 3,
JAR cell line; and lane 4, positive control. (B) Effect of anti-CD4 anti-
bodies. JAR cell line or PHA activated PBMC were incubated with anti-
CD4, OKT4A and Leu3a mAb before infection with HIV-1NL4.3 or HIV-
1BaL. Viral load was determined in the supernatant 4 days later.
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for all three chemokine receptors was detected in the JEG-3
cell line, we performed neutralisation experiments with dif-
ferent chemokines using HIVNL-4.3 or HIV-1BaL isolates for
infection in placental cells using this cell line. Neither the
infection with HIV-1BaL (R5) nor with HIV-1NL-4.3 (X4)
was significantly inhibited by any chemokine alone (MIP-
1, MIP-1, RANTES, Eotaxin, SDF-1) or by a combi-
nation of all of them (Fig. 3C). The small effect observed
with MIP-1 shown in Fig. 3 was not reproducible and not
statistically significant. In parallel control cultures, SDF-1
inhibited the entry of X4 virus in T cells and MIP-1,
MIP-1 and RANTES inhibited the entry of R5 virus in
macrophages, as expected (data not shown). Moreover, the
addition of heparin sulfate (HS) known to increase RAN-
TES inhibition did not alter HIV-1 infection of JAR cells by
itself or potent RANTES effect.
Adherence of HIV-1 infected T cell blast enhances
infection of placental cells
The above results indicate that placental cells could be
infected by HIV-1 albeit the extent of infection was rather
low. Thus, we tested if infected T-cell blasts, which are in
close contact to the trophoblast in the infected pregnant
Fig. 3. Chemokine receptor expression in placental cells. (A) CXCR4 expression detected by flow cytometry. Staining with CXCR4 or an isotype matched
irrelevant antibody in JAR and JEG-3 cell lines. (B) Expression of CCR3 and CCR5 mRNA. mRNA was extracted from placental cells and detected by
RT-PCR. Lanes 1 and 2, purified cytotrophoblast; lane 3, non-purified syncitiotrophoblasts; lane 4, JAR cell line; lane 5, JEG-3 cell line; lane 6, negative
control; lane 7, positive control (T cells for CXCR4 and monocyte/macrophagocytes for CCR3 and CCR5). Expression of CXCR-4 mRNA. Lanes 1 and 2,
purified cytotrophoblast; lane 3, JAR cell line; lane 4, JEG-3; and lane 5, negative control. (C) Effect of neutralizing chemokine receptors on HIV-1 infection
of placental cells. JEG-3 cell line was incubated with the chemokines RANTES, MIP-1, MIP-1, Eotaxin, SDF-1 or a mix of all of them 2 h at 37°C. JEG-3
cell line was also incubated with HS or HS  RANTES. Then, they were infected with HIV-1NL4.3 or HIV-1BaL, and viral load was quantified in the
supernatant 3 days later by RT-PCR. MCP-1 was added as a negative control. The results are the mean of three different experiments.
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women, can transfer more efficiently HIV-1 infection to
placental cells. For this, infected T-cell blasts were cultured
for 6 h with JAR monolayer cells. Then, monolayers were
extensively washed and viral load determined 3 days later.
As shown in Fig. 4A, the infection of placental cells by
infected T-cell blasts was more than 2 logs higher than
when free virus was used. Moreover, we could detect p24
antigen in the supernatant of JAR cells cocultured with
infected PBMC in contrast to cells infected with free virus
(not shown). To confirm that the virus was produced by JAR
cells and not by contaminating residual cells, we evaluated
the number of remaining attached PBMC to JAR monolayer
by counting radioactivity of T-cell blasts labelled with
[3H]thymidine prior infection. We could not detect any T
cells that remained bound. This strongly suggests that the
virus production observed came from infected JAR. The
above results suggested that infected T-cell blasts adhere to
placental cells and transfer the HIV-1 directly to them. To
further confirm the role of T cell adhesion in transmitting
the infection, JAR monolayer cells were incubated with
monoclonal antibodies against cell surface molecule known
to be involved in cell to cell contact. As shown in Fig. 4B,
the addition of anti-LFA-1 or the 2 integrins monoclonal
antibodies prior to and during the coculture period greatly
decreased HIV-1 infection of placental cells. Antibodies to
LFA-2 had same effect whereas anti-LFA-3 was basically
ineffective. Interestingly, the amount of inhibition of viral
infection measured in the same cultures after extensive wash-
ing to remove all bound lymphocytes correlated with the abil-
ity of those monoclonal antibodies to prevent firm adhesion of
infected T-cell blasts to JAR monolayers (Fig. 4C).
HIV-1 infection induces ICAM-1 in placental cells
Due the role of LFA-1 in T-cell blast binding to JAR
cells, we analysed the expression of LFA-1 counterreceptor
(ICAM-1) on JAR cells before or after HIV-1 infection.
Uninfected JAR cells expressed ICAM-1 but HIV-1 infec-
tion resulted in an enhanced expression of ICAM-1 both in
percentage of positive cells and fluorescence intensity (Fig.
5). Interestingly, this effect seems to require viral replica-
tion, since treatment of JAR cells with 100-fold more heat
inactivated virus had no effect on ICAM-1 expression.
Infected placental cells transfer HIV-1 to T-cells through
cell to cell contact
To address if infected placental cells can also transfer the
infection to PBMC, JAR cells previously infected with free
different viral isolates were cocultured with activated PHA
blasts and infection was quantified in the T cells by mea-
surement of p24 antigen. Detectable levels of p24 antigen
that increased over time were found in T-cell cultures (Fig.
6A). Since infected JAR cells do not release enough virus to
be detected by measuring p24 antigen levels, it is likely that
the virus detected came from infected PHA blasts. Interest-
ingly, when we repeated the same experiment using tran-
swells to separate the JAR cell HIV-1-infected line from the
PBMC, a decrease in more of 4 log10 in the virus titers by
Fig. 4. Transfer of HIV-1 infection from T cell infected blasts to placental
cells. (A) Infected PHA activated T-cell blasts can transfer HIV-1 infection
to placental cells. JAR monolayers were cultured for 6 h with HIV-1
infected PHA activated PBMC or with free HIV-1NL4.3 virus for 6 h. Then
the monolayers were extensively washed (10–20 times until no lympho-
cytes or other cells could be detected in the cultures). Three days later viral
load was evaluated in the supernatant. (B) Effect of antibodies to integrins
in HIV-1 infection or placental cells by infected PBMC. JAR cells were
treated or not (control) with the indicated antibodies (50g/ml) for 1 h
prior adding HIV-1 infected T-cell blasts. Six h later cultures were washed
and infection evaluated as above. (C) Effect of antibodies to integrins in the
adhesion of infected T-cell blasts to JAR monolayers. Cells were incubated
as above and the number of cell bound to JAR monolayer after 6 washes
was evaluated as described in materials and methods.
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either p24 (Fig. 6B) or in viral load (not shown) was ob-
served. This indicates that cell contact was required to
transfer the infectious virus to PBMC.
Next we tested if T-cell blasts can bind to the placental
cells. For this 2 106 T-cell blasts activated PBMC cells were
added to 106 JAR cells cultured for 6 h and then washed 6
times. A substantial number of lymphocytes can be observed
bound HIV-1-infected JAR monolayerss either by Normaski
microscopy (Fig. 7A) or by staining with anti-CD45 (Fig. 7B).
Since anti-CD45 is not expressed on JAR cells, the later
method only detected bound PBMC cells.
The results indicate so far the transfer of infection virus
to placental cells to PBMC was dependent on cell contact
and that ICAM-1 was increased in HIV-1 infected placental
cells. In order to study the influence of adhesion molecules
on the process, we tested the effect of several monoclonal
antibodies to cell adhesion molecules on the transfer of
infection to PBMC. The addition of human monoclonal
antibodies to LFA-1, the ligand of ICAM-1, significantly
prevented both adhesion (Fig. 7C) and the transfer of HIV-1
infection to PBMC (Fig. 7D). Moreover, a monoclonal
antibody against the common subunit of the 2 integrins
also inhibited viral infection and cell adhesion. In contrast,
monoclonal antibodies to other cell surface molecules af-
fected neither infection nor adhesion (Figs. 7C, D).
Discussion
HIV-1 vertical transmission has been related with immu-
nological and clinical characteristics of the carrier mothers
as well as with the virological characteristics of the trans-
mitting virus (Resino et al., 2000). Moreover, HIV-1 fetal
infection in utero could involve passing of virus or virus
infected cells through the placental barrier to the fetal com-
partment (Aplin, 1991). In this regard, viral gene expression
in chorionic membranes of HIV-1 infected pregnant women
has been reported (Chandwani et al., 1991; Maury et al.,
1989; Sheikh et al., 2000; Wabwire-Mangen et al., 1999).
Nonetheless, whether placental tissue is actually infected
and the origin and location of infected placental cells re-
mained unclear. The placental barrier is mainly composed
of syncytiotrophoblasts, acting as a physical barrier between
maternal and fetal blood and providing an immunological
protection against transfer of microbial pathogens and/or
maternal leukocytes from the mother to the fetal tissues.
Since fetal syncytiotrophoblasts are in direct contact with
maternal blood, maternal HIV-1 could vertically infect the
Fig. 6. Infection of T cell blasts by HIV-1-infected placental cells. A)
Kinetics of HIV-1 replication in infected placental cells-PBMC coculture.
PHA activated PBMC were cultured for 6 h with JAR cell line cultures
infected with any of the four viral isolates (HIV-1pNL4.3, HIV-1BaL, HIV-
12069I, HIV-11498I) and then extensively washed away and PBMC col-
lected. After 1, 4, and 10 days virus production was quantified by mea-
suring Agp24 in the supernatant of those T-cell cultures. B) Requirement
of physical contact between HIV-11498-infected placental cells and PBMC
to transfer the infection. Transwells were used (T) or not (NT) to separate
the JAR cell HIV-1 infected cells from PBMC during the 6 h coculture.
Four days later virus production was quantified.
Fig. 5. Induction of ICAM-1 adhesion molecule by HIV-1 infection in
placental cells. JAR cell line was infected with (0.1 m.o.i.) of the primary
HIV-11498 isolate, or mock infected with heat inactivated (hi) HIV-11498I
(10 m.o.i.). Three days after infection, cells were collected and stained with
ICAM-1 specific monoclonal antibody or with an isotype matched irrele-
vant antibody. Cell surface expression was detected by flow cytometry.
Shown inside the panels are the percentages of positive cells with respect
to the irrelevant matched monoclonal antibody.
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fetus using these cells as a carrier. However, the suscepti-
bility of the syncytiotrophoblast to HIV-1 infection is con-
troversial (David et al., 1992; Douglas et al., 1991; Douglas
and King, 1992).
Here, we have studied the susceptibility to HIV-1 infec-
tion of primary highly purified trophoblast cultures, and of
the human choriocarcinoma cell lines JAR and JEG-3.
These cell lines express many characteristics of placental
trophoblast (Kohler and Bridson, 1971; Pattillo and Gey,
1968). Our results indicate that both the purified trophoblast
and JAR and JEG-3 cell lines could be infected by HIV-1.
Moreover, the HIV-1 infection of placental cells was not
limited to just one particular viral strain. Interestingly, virus
isolated from HIV-1 infected women at delivery, HIV-12069I
R5 and HIV-11498I X4, had higher levels of replication in
placental cells than laboratory adapted viral strains. None of
the viral strains induced cytopathic effect in the placental
cells or cell lines after 6 days of infection (data not shown),
as it has already been reported by other investigators (Fa-
zely et al., 1995). After an initial increase in viral load the
infected cells continuously released low levels of virus that
remained constant through the cultures suggestive of per-
sistent infection.
Previous studies on HIV-1 infection of trophoblast with
free virus have shown low levels of infection (David et al.,
1992; Mano and Chermann, 1991; Zachar et al., 1991a),
while other authors have reported no infection at all (Doug-
las et al., 1991). These differences could be attributed to the
method of detection. By electron microscopy, the most
sensitive method to detect virions, HIV-1 infection and
rapid replication have been observed (Grewe et al., 1990;
Pauza et al., 1988; Stein et al., 1987). We used a very
sensitive method to detect virus, viral load quantification by
ultrasensible RT-PCR, that substantially increases during
the first 24 hours. We also detected proviral DNA by PCR
with specific primers. Both are clearly indicative of viral
infection of placental cells.
To investigate the putative mechanism used by the cell-
free virus to enter the placental cells we analysed CD4
receptor and CCR coreceptor expression in the trophoblast
cells, and in JAR and JEG-3 cell lines by flow cytometry
and/or RT-PCR. None of the cells express CD4 by flow
cytometry, whereas CD4 mRNA was only found in JEG-3
cell line and in poorly purified but not in highly purified
trophoblasts. CD4-mRNA expression in partially purified
trophoblast most likely derives from contaminating of Hof-
Fig. 7. Binding of T-cell blast to HIV-1 infected placental cells and transmission of viral infection. (A & B) Adherence of PBMC to infected placental cells.
JAR cells (105 cell/well) were cocultured with PHA-stimulated T-cell blast (2  106/well) during 4 h. Then, the cells were washed 3 times, fixed, and stained
with a monoclonal antibody anti-CD45-FITC. (A) A representative optical field by Normarski microscopy. (B) A representative field under fluorescence
microscope. (C & D). Effect of antibodies to integrins in the binding of T-cell blasts to infected JAR cells and transmission of HIV-1 infection. PHA blasts
were added to infected JAR cultures in absence (control) or in presence of the indicated monoclonal antibodies for 6 h. (C) PBMC were washed away
completely from the plate after the coculture period, plated at 106/ml and viral load measured 3 days later. (D) Finally, bound cells were evaluated after 6
washes as described in Materials and Methods.
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bauer cells (Maury et al., 1989; Sheikh et al., 2000). In
agreement with our results, lack of CD4 mRNA detected by
northern blot in the purified trophoblasts has been reported
in other works (Lairmore et al., 1993; Zachar et al., 1991a).
Furthermore, virus entry through CD4 is highly unlikely
since anti-CD4 antibodies did not block HIV-1 infection in
contrast to T cells.
The trophoblast cells as well as the JAR and JEG-3 cell
lines express CXCR4 and CCR5 mRNA whereas CCR3
was only detected in both cell lines but not in the purified
trophoblast cells. Furthermore, low CXCR4 expression by
flow cytometry was observed in a small percentage of JAR
and JEG-3 cell lines. However, our results clearly demon-
strated that viral infection of those placental cell line could
not be prevented by blocking the above mentioned HIV-1
coreceptors with their corresponding chemokines. Although
it is well known that HIV-1 infects T helper lymphocytes
and monocytes/macrophages via CD4 receptor, HIV-1 tro-
pism could be wide. Thus, HIV could infect different tissues
in vivo (colon, retina and cervix) as well as CD4 negative
cells in vitro (glioma, neuroblastoma, rabdomiosarcoma,
hepatocellular carcinoma, fibroblasts, and CD34 bone
marrow precursors) (Li et al., 1990; Obrego´n et al., 1999).
These results are consistent with different infection mech-
anisms, which could imply either a surface protein different
from CD4 or a protein-independent endocytosis mecha-
nism. Free virus could enter the trophoblast cells by using
alternative receptors, which included Fc receptors, galacto-
sil ceramide and complement receptors. Indeed, some of
these receptors have involved HIV-1 infection in neural
cells and macrophages (Harouse et al., 1991; Lieberman et
al., 1999; Robinson et al., 1988; Takeda et al., 1988).
Interestingly, we have found that HIV-1 infection of
placental cells is much more efficiently produced by in-
fected T-cell blasts than by free virus, in agreement with
previous reports (Bourinbaiar and Nagorny, 1993; Douglas
et al., 1991; Li and Burrell, 1992; Phillips and Tan, 1992;
Sato et al., 1992). We further demonstrated that this effect
was dependent on 2-integrin mediated leukocyte adhesion.
Thus, antibodies to LFA-1 or to the common subunit of 2
integrins significantly prevented transfer of HIV-1 infection
from T-cell blasts to placental cells. Besides, the inhibitory
activity of these monoclonal antibodies correlated with their
ability to block firm adhesion of T cells to placental mono-
layer. Our results are somewhat contradictory with a recent
report that indicates that infected PBMC-placental cells
contact favours transcytosis of HIV-1 but not infection of
placental cells (Lagaye et al., 2001). The different cell lines
used in both studies may explain the observed differences.
However, we have seen HIV-1 infection in normal tropho-
blasts in addition to two transformed cell lines, thus sup-
porting the ability of HIV-1 to infect cytotrophoblasts.
Thus, HIV-1 entry into the placental trophoblast could be
the result of either direct viral infection or the interaction
between infected lymphocytes and trophoblast cells, although
it is greatly enhanced in the latter case. It would be possible
that adhesion between T-cell blast and trophoblast cells stimu-
lates viral endocytosis or induces the expression of some sur-
face molecules in placental cells, which increased virus entry.
In addition, infected placental cells can transfer infection
to PBMC. This effect requires cell to cell contact and is also
mediated by a LFA-1 dependent mechanism. Moreover, the
rise in ICAM-1 in placental cells after HIV-1 infection may
not only increase leukocyte adhesion and transfer of viral
infection, but also allow the transmigration of PBMC through
placenta to the fetus (Xiao et al., 1997). This fact may have
some additional relevant consequences, since these maternal
cells not only can transmit the virus but also they could trigger
an immune response against the fetus. This hypothesis
would be in agreement with the high percentage of miscar-
riage in HIV-1-infected women (Langston et al., 1995).
Previous studies have indicated the enhancing role of
LFA-1 and ICAM-1, which are also expressed by virion them-
selves, on the initial processes of viral infection by favoring
cell to cell contact (Hioe et al., 2001; Liao et al., 2000).
It was unclear whether placental cells contain virus in
relative or absolute latency (Vicenzi and Poli, 1994). La-
tency is related with the absence of infectious virus but with
the presence of proviral DNA integrated in the genomic
cellular DNA (McCune, 1995). Besides, mature virus has
been rescued from latent infection through coculture with
susceptible cells or after cellular activation (David et al.,
1992), also indicative of a latent state. Our results are in
agreement with a relative latent state since proviral DNA
could be detected and viral replication was more intense at
early than at late times after infection and declining there-
after. The fact that HIV-1 replication could be induced upon
cell to cell contact with PBMC also supports a latent state.
In any case, the virus produced by placental infected cells
was infectious, since placental infected cells can transfer the
infection to T cells in cocultures.
In summary our results suggest that placental tropho-
blasts are actually infected by HIV-1 since this infection is
mediated by a mechanism different from the use of the
correceptors normally used by the virus to enter into T cells.
More interestingly, infected T-cell blasts transfer the infec-
tion to placental cell much more efficiently than free virus.
This effect depends on cell adhesion mediated by LFA-1
integrin. HIV-1 infection of placental cells enhances
ICAM-1 expression and promotes leucocyte adherence to
placental cells. Those placental cells may in turn pass the
virus to T cell of the fetus again by a mechanism also
involving LFA-1. Those results may help to explain vertical
HIV-1 transmission in utero.
Materials and methods
Cells and virus stocks
Cytotrophoblasts were purified from normal term human
placentas, after vaginal delivery, as described by Kliman et
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al. (1986). Briefly, several cotyledons were minced and
digested in a calcium- and magnesium-free Hanks’ solution
(CMF Hanks’) containing 0.125% trypsin (Gibco, Paisley,
Scotland, UK) and 0.2 g/mL Dnase I (Sigma Chemical
Co., St. Louis, MO). The supernatants were layered over
fetal calf serum (FCS) (Biochrom KG, Seromed, Berlin,
Germany) centrifuged at 2000 rpm for 10 min and the
resultant pellets were resuspended in DMEM containing 25
mM HEPES and 25 mM glucose (DMEM-HG). This sus-
pension was layered over a preformed discontinuous Percoll
gradient (Pharmacia, Uppsala, Sweden) made up in Hanks’
solution (from 70% to 5% Percoll in 5% steps). The gradient
was centrifuged at 1.200 g at room temperature for 20
minutes. Cells sedimenting at densities between 1.051 and
1.063 specific gravity were collected. The density was de-
termined by running parallel gradients loaded with density
marker beads (Pharmacia).
Cytotrophoblasts were further purified by negative selec-
tion with anti-HLA antibodies. Immunomagnetic separation
(Dynabeads, Dynal A.S, Oslo, Norway) was performed us-
ing monoclonal antibodies against human HLA-ABC (class
I) and HLA-DP, DQ, DR (class II) to obtain purified cy-
totrophoblast (Lairmore et al., 1993). The purity of the
isolated cells was confirmed by flow cytometry with anti-
cytokeratin antibodies (Dako, AIS, Denmark). The purified
cells were cultured in DMEM-HG 20% FCS, 2 mM L-
glutamine (ICN Pharmacenticals, Costa Mesa, CA), 100
IU/ml penicillin and 100 g/ml streptomicin (Gibco, Pais-
ley, Scotland, UK) at a concentration of 106 cells/ml.
Transformed trophoblastic cell lines JAR (ATCC HTB
144) (Pattillo and Gey, 1968) and JEG-3 (ATCC HTB 36)
(Kohler and Bridson, 1971) were routinely grown in RPMI
(Biochrom KG seromed, Berlin, Germany) supplemented
with 10% heat-inactivated FCS, 2 mM L-glutamine (ICN
Pharmaceuticals), 100 IU/ml penicillin and 100 g/ml
streptomycin at 37°C in a humidified atmosphere of 5%
CO2. Peripheral blood mononuclear cells (PBMC) were
isolated from blood by Ficoll-Hipaque density gradient cen-
trifugation (Pharmacia) as described (Munoz-Fernandez et
al., 1996).
HIV-1NL4.3 (X4), HIV-1BaL (R5) established isolates or
HIV-12069I (R5), and HIV-11498I (X4) primary clade B iso-
lates from HIV-1 infected pregnant women were used. Pro-
duction and titration of the viral stocks were as described
(San Jose et al., 1998).
HIV-1 infection of placental cells
Trophoblasts, JAR, or JEG-3 cells were cultured in
plates of different size depending of the experiments (Costar
Corning, Cambridge MA). The various virus isolates ob-
tained in our laboratory were added to individual cultures, at
0.1 m.o.i. and maintained for 4 h at 37°C. Then cultures
were extensively washed with warm RPMI to remove all
free virus (between 10 and 20 times). In those conditions we
detected proviral DNA by nested PCR as previously de-
scribed (Munoz-Fernandez et al., 1996). The placental cells
were cultured in 10% FCS RPMI and virus titer and were
quantified in the supernatant at various times after infection
by p24 antigen production (INNOTEST HIV Antigen mAb,
Innogenetics, Zwijndrecht, Belgium) or by the quantifica-
tion of HIV-RNA (viral load) (Amplicor-HIV MonitorTM
test, Roche, NJ). Mock infection was carried out with heat-
inactivated (hi) viral preparations. Cell lines were
trypsinized every three culture days, washed and plated at
appropriate concentrations.
To block viral entry, JEG-3 cultures were preincubated
1 h at 37°C with the monoclonal antibodies anti-CD4,
OKT4A and Leu3a (10 g/ml) and with the chemokines
MIP1-, MIP-1, RANTES, Eotaxin, SDF, and MCP-1
cytokines (1 g/ml) (R&D Systems, Minneapolis, MN) or
heparin sulfate (500 ng/mL) alone or in combination with
some chemokines in 24 well plates before adding HIV-
1NL4.3 (0.1 m.o.i.) or HIV-1BaL (0.1 m.o.i). Three days later
viral load was quantified in culture supernatants.
Cocultures of PBMC and placental cells
To analyze the efficiency of HIV-transfer between T-cell
blasts and trophoblast as well as adhesion, several different
coculture assays were carried out.
For this PBMC from healthy HIV seronegative donors
were isolated from whole blood by Ficoll Hypaque (Phar-
macia) centrifugation basically as described (Munoz-Fer-
nandez et al., 1996). T-cell blasts were obtaining by activa-
tion of PBMC (106/ml) in RPMI-1640 medium
(BIOCHROM) supplemented with 10% fetal calf serum
(FCS) with 2 g/ml of PHA for 48 h at 37°C. Next they
were incubated for 16 h with 40 U/ml of human IL-2. The
cells were infected with 1 m.o.i HIV-1, for 2–4 h. Cells
were washed with RPMI-1640 medium (BIOCHROM) sup-
plemented with 10% FCS twice. Anti-human LFA-1
(CD11a), human LFA-2 (CD2), human 2 integrins
(CD18), human LFA-3 (CD58), all of them purchased from
Endogen (USA) were added at a concentration of 50 g/ml
to the JAR cell line for 2 h where indicated. Then HIV-1
infected T-cell blasts (2  106) were added to JAR mono-
layers (106) and cocultured for 6 h at 37°C in presence of
the corresponding antibodies. T-cell blasts were washed
extensively (20 times) and with EDTA to remove all PBMC
and cultures were incubated for 72 h at 37°C.
Transfer of HIV-1 from T cells to trophoblast cells
To study the adhesion of infected T cell to the tropho-
blast layer, T-cell blasts were labeled with [3H]thymidine
(10 Ci) for 16 h and washed prior to use in the assay. Thus,
after culturing infected and labeled T-cell blasts as above,
the cultures were washed 6 times to allow specifically in-
teracting T cells to remain bound to the plates. Then the
radioactivity in the remaining trophoblast cultures were
evaluated and the number of T cells bound extrapolated by
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determining in the control specific radioactivity per T-cell
blast.
Transfer of HIV-1 from infected trophoblast cells to PBMC
Cocultures of infected placental cells (106) with T cell
blast (2  106) were carried out as above with the cells in
close contact for 6 h, or separated by 0.4 m pore size
transwells (Costar Corning, Cambridge MA) to avoid cell-
cell interactions between both cellular types. Then the
PBMC were collected by extensive washing and plating and
at different days production of Ag p24 measured.
The adhesion of T-cell blast to infected JAR cells was
evaluated by 3 independent methods. After 6 h of coculture
in the presence of various antibodies where indicated, T-cell
blast and JAR, the cultures were washed 6 times to remove
nonadhered PBMC. Thus, the remaining cells bound to
monolayers were evaluated by A) Normasky microscopy;
B) fluorescence microscopy after staining with an anti-
human CD45-FITC monoclonal antibody (JAR cells do not
express CD45); or C) quantifying the amount of radioactiv-
ity bound to the plates. For this, T cells were labelled with
[3H]thymidine as mentioned above previous to addition to
the plates. Radioactivity was measured in a scintillation
counter, and the number of cells bound extrapolated.
Flow cytometry
Cell surface expression of CD4, CCR5 and CXCR4 in
placental cells was evaluated by direct flow cytometry as
previously described (Munoz-Fernandez et al., 1996).
Briefly, placental cells were recovered by treatment of the
monolayers with 0.02% EDTA-containing RPMI medium,
and subsequently incubated with fluorescein isothiocyanate-
labeled anti-CD4 Leu3a (Becton-Dickinson) and phyco-
eritrin anti-CXCR-4 (Pharmigen) monoclonal antibodies or
with irrelevant fluorescein isothiocyanate or phycoerithin-
labeled monoclonal antibodies as negative controls, for 30
min at 4°C. Then, the cells were washed in the above buffer
and surface fluorescence was determined in a FACS-scan
cytometer (Becton-Dickinson, Franklin Lakes, NJ). A min-
imum of 10,000 cells per point were analysed.
The purity of trophoblast suspension after magnetic neg-
ative selection was also evaluated by intracellular anti-
cytokeratin staining using flow cytometry. For this, cells
were washed with PBS twice and incubated 30 minutes at
4°C in PBS 2% paraformaldehide. After two washes in PBS
they were incubated in 0.5% Twin PBS 15 minutes at 4°C
in the dark. Cells were incubated with FITC-anti-cytokera-
tin antibody or with an irrelevant FITC bind antibody as
negative control, and washed in 2% BSA PBS. Purity was
greater than 97% in all experiments.
RT-PCR from placental cells
mRNA from 105 placental cells was isolated with oligo
(dT) coated magnetic beads and subsequent reverse tran-
scription (Series 9600, Promega, Corps., Madison, WI),
according to the manufacturer’s instructions. DNA ampli-
fication was performed with 5 or 10 l of cDNA. GAPDH
amplification was used as positive mRNA purification
control. The following primers were used: CD4 sense
(5-GTGAACCTGGTGGTGATGAGAGC-3-) and CD4
antisense (5-GGGGCTACATGTCTTCTGAAACCGGTG-
3); CXCR4 sense (5-GACCGCTACCTGGCCATT-3)
and CXCR4 antisense (5-GTTGTAGGGCAGCCA-3) (He,
1997); CCR3 sense (5-TCCTTCTCTCTTCCTATCA-3) and
CCR3 antisense (5-GGCAATTTTCTGCATCTG-3) (He,
1997); and CCR5 sense (5-AATCTTCTTCATCATCCTCC-
3) and CCR5 antisense (5-TCTCTGTCACCTGCATAGC-
3) (He et al., 1997).
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